Symbol="AXSM"
AssetType="Common Stock"
Name="Axsome Therapeutics Inc"
Description="Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York."
CIK="1579428"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3384395000"
EBITDA="-141259392"
PERatio="None"
PEGRatio="0"
BookValue="2.568"
DividendPerShare="0"
DividendYield="0"
EPS="-3.22"
RevenuePerShareTTM="3.447"
ProfitMargin="-1.097"
OperatingMarginTTM="-0.99"
ReturnOnAssetsTTM="-0.374"
ReturnOnEquityTTM="-2.509"
RevenueTTM="144613000"
GrossProfitTTM="45939500"
DilutedEPSTTM="-3.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="113.91"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="134.76"
PriceToBookRatio="20.66"
EVToRevenue="121.47"
EVToEBITDA="-20.98"
Beta="1.914"
num_52WeekHigh="91.29"
num_52WeekLow="35.16"
num_50DayMovingAverage="75.93"
num_200DayMovingAverage="65.52"
SharesOutstanding="46573200"
DividendDate="None"
ExDividendDate="None"
symbol="AXSM"
open="72.17"
high="74.80"
low="71.52"
price="73.91"
volume="1104889.00"
latest_trading_day="2023-07-06"
previous_close="72.77"
change="1.14"
change_percent="1.5666%"
aroon_positive_momentum_days="54"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="915956"
Change_recent_avg="0.09"
Delta_recent_avg="3.36"
Variance_recent_avg="1.68"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="558"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0041.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="700"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_positive_thumbnail_id_2="653"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0055.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
